CVR: 37162949
DKK -1,500
Gross profit
Net result: DKK -1,500
No owners listed
CVR · view ownership and management
Director role ended: Mette Wiik Kristensen
CVR · 25/05/2021
View the full event history
Incensus Pharma IvS was a Danish company of the type Iværksætterselskab based in Hinnerup, founded in 2015 and dissolved in 2021. The company was registered under the industry Forskning og eksperimentel udvikling indenfor bioteknologi. In 2020, the company reported a gross profit of DKK -1,500 and a net result of DKK -1,500 compared with DKK -1,625 the year before. Equity in the 2020 report amounted to DKK -7,244.
Source: annual reports filed with the Danish Business Authority.
Screen owners and management against the Danish FSA's official PEP lists
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningNo. Incensus Pharma IvS is registered in the Danish CVR register with the status Dissolved and ceased on 25 May 2021.
Incensus Pharma IvS was founded on 16 October 2015.
Incensus Pharma IvS was registered under the industry Forskning og eksperimentel udvikling indenfor bioteknologi (industry code 721100).
In 2020, Incensus Pharma IvS reported a gross profit of DKK -1,500.
Incensus Pharma IvS was located at c/o Wiik Pharma ApS, Bogøvej 15, 8382 Hinnerup.
The CVR number of Incensus Pharma IvS is 37162949.
As of May 25, 2021, Mette Wiik Kristensen has stepped down as director of Incensus Pharma IvS.
Incensus Pharma IvS was dissolved on May 25, 2021.
Incensus Pharma IvS has published its annual report for 2020. Gross profit came to DKK -1,500, and the net result was DKK -1,500.
Incensus Pharma IvS has published its annual report for 2019. Gross profit came to DKK -1,484, and the net result was DKK -1,625.
Incensus Pharma IvS has published its annual report for 2018. Gross profit came to DKK -1,250, and the net result was DKK -1,352.
Incensus Pharma IvS has published its annual report for 2017. Gross profit came to DKK -1,250, and the net result was DKK -1,271.
Incensus Pharma IvS has published its interim report for the period October 16, 2015 – December 31, 2016.
As of May 2, 2016, Mette Wiik Kristensen is registered as director of Incensus Pharma IvS.
As of May 2, 2016, Kresten Tranberg Johansen has stepped down as director of Incensus Pharma IvS.
As of October 16, 2015, Kresten Tranberg Johansen is registered as director of Incensus Pharma IvS.
Incensus Pharma IvS was founded on October 16, 2015.
